You may have seen clips of Team G and other members fron UCLP in the MS reports by Shift MS
Here is the full interview of Prof B talking to Mariam
and then Prof G…as you can see the minute per answer (look at the egg-timer) just wasn’t going to happen.
NB. International Collaborative has been rebranded as the MS Alliance
View it bit by bit
Some people think and complain that I am a “ghost writer” maybe a cyborg collective…today they are right! I am a ghost, Happy Halloween 🙂
Thamilarasan M, Hecker M, Goertsches RH, Paap BK, Schröder I, Koczan D, Thiesen HJ, Zettl UK. Glatiramer acetate treatment effects on gene expression in monocytes of multiple sclerosispatients. J Neuroinflammation. 2013 Oct;10(1):126. [Epub ahead of print] BACKGROUND: Glatiramer acetate (GA) is a mixture of synthetic peptides used in the treatment of patients with relapsing...
How a designer is helping researchers explain MS science What makes Team G different..well many things But Art, Design and Science can mix. Alison a Designer in our group, and a student, has been instrumental in the development and implementation of many of our public engagement activities as well as working to improve our patient experience. Read More on the Post from the MS Trust (Click...
Veauthier C. Younger age, female sex, and high number of awakenings and arousals predict fatigue in patients with sleep disorders: a retrospective polysomnographic observational study. Neuropsychiatr Dis Treat. 2013;9:1483-1494. Epub 2013 BACKGROUND:The Fatigue Severity Scale (FSS) is widely used to assess fatigue, not only in the context of multiple sclerosis-related fatigue, but...
Ben-Ami E, Miller A, Berrih-Aknin S. T cells from autoimmune patients display reduced sensitivity to immunoregulation by Mesenchymal Stem Cells: Role of IL-2. Autoimmun Rev. 2013 Oct. doi:pii: S1568-9972(13)00171-7. 10.1016/j.autrev.2013.09.007. [Epub ahead of print] Mesenchymal stem cells (MSCs) are multipotent progenitor cells which have been shown to possess broad immunoregulatory and...
Lonergan R, Kinsella K, Kelly S, Duggan M, Scott J, O’Rourke K, Lynch T, Hutchinson M, Tubridy N, McGuigan C. Does JCV antibody positivity encourage cessation of Natalizumab therapy in Multiple sclerosis. J Neurol Neurosurg Psychiatry. 2013 Nov;84(11):e2 BACKGROUND: Natalizumab, a monoclonal α-4-integren receptor antibody, is an effective immunomodulator in highly active...
You have been asking when is the Next Research Day in London will be. Well I cannot yet say for definite because Team G are not doing the organization. Next time it is being done by our friends in UCLP at University College London. They have yet to definitively select the venue and find the funds to support the day.Time is ticking.. At present they have been looking into the...
Leuenberger T, Paterka M, Reuter E, Herz J, Niesner RA, Radbruch H, Bopp T, Zipp F, Siffrin V. The Role of CD8+ T Cells and Their Local Interaction with CD4+ T Cells in Myelin Oligodendrocyte Glycoprotein35-55-Induced Experimental Autoimmune Encephalomyelitis. J Immunol. 2013 Oct. [Epub ahead of print]T cells have an essential role in the induction of multiple sclerosis and its animal model...
Kappos L, Gold R, Arnold DL, Bar-Or A, Giovannoni G, Selmaj K, Sarda SP, Agarwal S, Zhang A, Sheikh SI, Seidman E, Dawson KT.Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: The DEFINE study. Mult Scler. 2013 Oct 22. [Epub ahead of print] BACKGROUND:Oral BG-12 (dimethyl fumarate), approved for the treatment of the relapsing...